Intranasal oxytocin administration

PreclinicalSmall molecule

IInternational Research Training Group 2804

Intranasal oxytocin administration is one of 6 small molecule programs targeting Oxytocin. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

OxytocinRecruiting

OxytocinPreclinical

Recruiting

Competition

Competitive Landscape

5 competitors in Oxytocin

#DrugCompanyPhaseTrials

Pitocin

RRetrophin

Approved

108 2

Intranasal Oxytocin

UUniversity of Electronic Science and Technology of China

Phase 2

18 3

Half-Dose Oxytocin

NNorthwestern University

Phase 3

2 4

Pitressin

AAultman Health Foundation

Preclinical

1 5

Norethindrone Acetate-Ethinyl Estradiol

EElizabeth Austen Lawson

Phase 1

1 6

Intranasal oxytocin administration

IInternational Research Training Group 2804

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2026

N/ARecruiting

Oxytocin

NCT06222749

Clinical

Trials by Indication[1]

Oxytocin1 trial

Oxytocin and Reward Processing in Women

Recruiting·IInternational Research Training Group 2804·N/A·NCT06222749·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Intranasal oxytocin administration. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Intranasal oxytocin administration compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Intranasal oxytocin administration. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — International Research Training Group 2804 company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: IInternational Research Training Group 2804

Intranasal oxytocin administration

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2026

Trials by Indication[1]

Oxytocin1 trial

References

Drug Info

Quick Facts

Related News